Latest Business Acquisitions News

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.

Cuscal Limited has completed its acquisition of Indue Limited, targeting significant cost synergies and board refreshment to strengthen its payments business.

Ridley Corporation has completed its $300 million acquisition of Incitec Pivot Fertilisers, marking a strategic expansion into a new growth pillar within Australian agricultural services.

MPower Group has finalized the sale of nearly all its assets to Wollemi Energy Group for about $19 million, setting the stage for a potential capital return or a new business acquisition.

Spirit Technology Solutions reported a 12.7% revenue increase and a 562% surge in underlying EBITDA for FY25, driven by strategic acquisitions that have positioned cyber security as its fastest growing segment.

NRW Holdings reported a 12.2% revenue increase to $3.27 billion in FY25, offset by a significant impairment linked to OneSteel receivables. The company declared a final fully franked dividend of 9.5 cents per share, underscoring confidence despite challenges.

Redox Ltd reported a robust 9.4% increase in revenue for FY25, supported by strong volume growth and three strategic acquisitions, despite margin compression and a challenging macroeconomic backdrop.

MPower Group has entered a binding agreement to sell its renewable energy assets and platform to Wollemi Energy Group for approximately $19 million, marking a pivotal shift in its business strategy.

Life360, Inc. reported a strong Q1 2025 with 32% revenue growth to $103.6 million, driven by a 33% increase in subscription revenue and a return to profitability with $4.4 million net income. The company also advanced its strategic positioning through a $4.5 million acquisition and a key partnership.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

MCS Services Ltd reports a decline in cash and receivables for Q2 FY2025 while advancing new traffic management contracts and growth initiatives. The company also confirms the collapse of a planned reverse takeover with NJ Ashton Pty Ltd.